longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus

MSN
Aug 16, 2026 at 01:20 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Wall Street indices dipped slightly, but the healthcare sector gained nearly 1%. Eli Lilly filed six lawsuits against black-market sellers of unapproved retatrutide. Hims & Hers Health shares fell after a Q2 profit miss despite strong revenue guidance. Jazz Pharmaceuticals agreed to acquire Actio Biosciences for up to $1.32 billion to expand its rare epilepsy portfolio. Meanwhile, experts warn that splitting the MMR vaccine could take a decade due to regulatory and manufacturing hurdles.

Wall Street ended lower Friday as investors took a pause following the S&P 500’s latest record high, capping a week that saw strength spread across technology, software, small caps, and commodities. The technology-heavy Nasdaq Composite declined 0.2%, while the benchmark S&P 500 slipped 0.1%. The blue-chip Dow Jones Industrial Average also finished...

Login to unlock361characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting
  • Apr 1, 2026 at 01:21 PMFrom Weight-Loss Drugs to Sleep Disorders! Lilly Plans to Acquire Centessa for Up to $7.8 Billion, Entering Narcolepsy a…
  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 24, 2026 at 01:55 PMNovo Nordisk will significantly reduce the price of its weight loss drug in the U.S. next year, with a maximum reduction…

Related Stocks

Jazz Pharma

Jazz Pharma

USJAZZ

+2.21%

Merck

Merck

USMRK

-0.54%

Hims & Hers Health

Hims & Hers Health

USHIMS

+0.26%

LongbridgeAI